Preclinical Study: Reversing Alzheimer’s by Targeting Epigenetic Enzymes and Glutamate Receptors
Research published in the journal Brain reveals a new approach to Alzheimer’s disease (AD) that may eventually make it possible to reverse memory loss, a hallmark of the disease in its late stages. The team, led by University of Buffalo scientists, found that by focusing on gene changes caused byRead
